Adjust Use of Contrast for Pain Procedures During Shortage
Recommendations have been issued by the ASRA and Pain Medicine for interventional pain procedures during the current contrast shortage.
Recommendations have been issued by the ASRA and Pain Medicine for interventional pain procedures during the current contrast shortage.
Compared with its use for chronic pain, reliable evidence to support the use of cannabis to treat anxiety is lacking and available data are “conflicting.” To bring clarity to the issue, researchers conducted a retrospective database study of Canadian medical cannabis patients.
Baseline cannabinoid use is associated with higher sedation use during endoscopy with endoscopist-directed conscious sedation.
Researchers examined meaningful within-patient changes in WOMAC using data from 3 trials that included patients with moderate to severe hip and knee osteoarthritis.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
The FDA urges consumers to buy prescription drugs, such as Adderall, from state-licensed US pharmacies or physicians located in the US.
Female trauma patients have longer delays in trauma care and an increased likelihood of discharge to long-term care facilities compared with male trauma patients.
Researchers have developed a system of quantitative EEG analysis which delivers an EEG phenotype associated with depression or anxiety that is customizable to each patient.
Visipaque and Omnipaque are radiographic contrast agents.
Researchers sought to understand the epidemiology of pain in patients with IBD and identify pain characteristics with a focus on central sensitization.